0314 GMT - IHH Healthcare's long-term prospects may remain optimistic, given its strategic plan for organic and inorganic growth, RHB IB analyst Oong Chun Sung says in a note. The healthcare service provider is targeting 4,000 new beds by 2028, with key expansion focussed on Malaysia and India, he notes. Oong cuts IHH's 2025-2026 earnings forecast by 3% and 1%, respectively, to factor in higher finance costs. RHB cuts IHH Healthcare's target price to MYR8.70 from MYR9.10 as its 2024 earnings came in below estimates, while maintaining a buy rating on the stock. Shares are 1.1% higher at MYR7.39. (yingxian.wong@wsj.com)
(END) Dow Jones Newswires
February 27, 2025 22:14 ET (03:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.